DOI: 10.1039/A904971A
(Paper)
Reference Section for: Chem. Commun., 1999, 1637-1638
A fluorescent probe for the detection of NAD(P)H
(Note: The full text of this document is currently only available in the PDF Version )
Carl A. Roeschlaub, Nicola L. Maidwell, M. Reza Rezai and Peter G. Sammes
Abstract
NAD(P)H may be monitored by using reduction to release the fluorophore umbelliferone from a precursor conjugate with a quinoxalinium salt.
References
- S. K. Jonas, C. Benedetto, A. Flatman, L. Micheletti, C. Riley, P. A. Riley, D. Spargo, M. Zonca and T. F. Slater, Br. J. Cancer, 1992, 66, 185 CAS.
- L. P. Candeis, D. P. S. MacFarlane, S. L. W. McWhinnie, N. L. Maidwell, C. A. Roeschlaub, P. G. Sammes and R. Whittlesey, J. Chem. Soc., Perkin Trans. 2, 1998, 2333 RSC.
- D. B. Cook and C. H. Self, Clin. Chem., 1993, 39, 965 CAS.
- H. Shah, A. M. Saranko, M. Harkonen and H. Adlercreutz, Clin. Chem., 1984, 30, 185 CAS.
- For a review see A. Voller and D. E. Bidwell, Enzyme Immunoassays, in Alternative Immunoassays, ed. W. P. Collins, Wiley, Chichester, 1985, pp. 77–86 Search PubMed.
- E. Seidler, The Tetrazolium-Formazan System: Design and Histochemistry, in Progress in Histochemistry and Cytochemistry, Gustav Fischer Verlag, Stuttgart, 1991, vol. 24, pp. 1–86 Search PubMed.
- G. Blankenhorn, in Pyridine Nucleotide Dependent Dehydrogenases, ed. H. Sund, W. de Gruyter & Co., Berlin, 1997, pp. 185–205 Search PubMed.